OPK Stock Summary and Trading Ideas (Opko Health | NASDAQ:OPK)

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

Opko Health trades on the NASDAQ stock market under the symbol OPK.

As of April 9, 2025, OPK stock price declined to $1.40 with 1,731,757 million shares trading.

OPK has a beta of 0.46, meaning it tends to be less sensitive to market movements. OPK has a correlation of 0.04 to the broad based SPY ETF.

OPK has a market cap of $1.11 billion. This is considered a Small Cap stock.

Last quarter Opko Health reported $184 million in Revenue and $.02 earnings per share. This beat revenue expectation by $28 million and exceeded earnings estimates by $.13.

In the last 3 years, OPK traded as high as $3.55 and as low as $.85.

The top ETF exchange traded funds that OPK belongs to (by Net Assets): VTI, IWM, VB, VXF, IWN.

OPK has outperformed the market in the last year with a return of 0.0%, while the SPY ETF lost -3.0%. In the last 3 month period, OPK beat the market returning -5.4%, while SPY returned -15.6%. However, in the most recent 2 weeks OPK has underperformed the stock market by returning -22.2%, while SPY returned -13.8%.

OPK support price is $1.42 and resistance is $1.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OPK shares will trade within this expected range on the day.